Søren Jensen
Vorsitzender bei Tecleaf ApS
Aktive Positionen von Søren Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tecleaf ApS | Vorsitzender | - | - |
Samfonden | Direktor/Vorstandsmitglied | - | - |
Fulton Foundation | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Søren Jensen
Ehemalige bekannte Positionen von Søren Jensen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.07.2021 | 04.02.2023 |
Independent Dir/Board Member | 31.07.2021 | 04.02.2023 | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Direktor/Vorstandsmitglied | 01.09.2020 | - |
Independent Dir/Board Member | 01.09.2020 | - |
Ausbildung von Søren Jensen
University of Aarhus | Graduate Degree |
Statistik
International
Dänemark | 5 |
Vereinigte Staaten | 3 |
Operativ
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Chairman | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLARITY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
Tecleaf ApS | |
Samfonden | |
Fulton Foundation |
- Börse
- Insiders
- Søren Jensen
- Erfahrung